Yifang Biological: It is expected that the net profit will be a loss of 317 million yuan in 2025.

Yifang Biotechnology announced that it is expected to achieve operating income of 37.3253 million yuan and a net profit attributable to the owners of the parent company of -317 million yuan in 2025. The main financial data for this reporting period is preliminary accounting data and has not been audited by an accounting firm. In 2025, the performance of the company will be mainly affected by the intensity of research and development investment and the composition of revenue.